PONTECORVO, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 1.283
EU - Europa 385
AS - Asia 187
SA - Sud America 5
AF - Africa 3
Totale 1.863
Nazione #
US - Stati Uniti d'America 1.269
IT - Italia 144
SE - Svezia 108
IN - India 82
CN - Cina 51
SG - Singapore 45
DE - Germania 35
FI - Finlandia 32
UA - Ucraina 14
RO - Romania 13
CA - Canada 12
BG - Bulgaria 9
GB - Regno Unito 7
HK - Hong Kong 6
NL - Olanda 6
AR - Argentina 5
IE - Irlanda 5
FR - Francia 4
TG - Togo 3
MK - Macedonia 2
MX - Messico 2
AL - Albania 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
IL - Israele 1
LU - Lussemburgo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TR - Turchia 1
Totale 1.863
Città #
Fairfield 225
Ashburn 123
Chandler 108
Woodbridge 91
Houston 82
Cambridge 68
Seattle 64
Rome 60
Wilmington 60
Dearborn 53
Ann Arbor 37
Princeton 33
Plano 30
Beijing 25
Lawrence 24
San Paolo di Civitate 23
Singapore 22
Millbury 15
Boston 14
Norwalk 14
San Diego 14
Helsinki 10
Sofia 9
Andover 8
Fremont 7
Ottawa 7
Phoenix 7
Des Moines 6
Hong Kong 6
San Mateo 6
Dublin 5
Federal 5
Hefei 5
Milan 5
New York 5
Toronto 5
Venezia 5
Fasano 4
Kunming 4
Amsterdam 3
Atlanta 3
Bühl 3
Jacksonville 3
Lomé 3
Bad Bellingen 2
Bari 2
Buffalo 2
Genzano 2
Guangzhou 2
Hyderabad 2
Jinan 2
Laurel 2
Mannheim 2
Munich 2
Nanchang 2
Nanjing 2
Padova 2
Paris 2
San Jose 2
Santa Maria La Carita 2
Skopje 2
Terni 2
Trumbull 2
Bangkok 1
Bern 1
Bonndorf 1
Bratislava 1
Bremen 1
Brno 1
Chengdu 1
Chicago 1
Chongqing 1
Colleferro 1
Falls Church 1
Frankfurt am Main 1
Fuzhou 1
Genzano di Roma 1
Grafing 1
Gunzenhausen 1
Haikou 1
Leawood 1
Lissone 1
Los Angeles 1
Luxembourg 1
Madrid 1
Nanning 1
Nürnberg 1
Pomezia 1
Redmond 1
Riva 1
Saint Louis 1
San Francisco 1
Santa Maria Nuova 1
Shenyang 1
Simi Valley 1
Southwark 1
Tel Aviv 1
Tirana 1
Venustiano Carranza 1
Wuhan 1
Totale 1.384
Nome #
Attention-related changes in short-term cortical plasticity help to explain fatigue in multiple sclerosis 103
Reactivation of hepatitis B virus with immune-escape mutations after ocrelizumab treatment for multiple sclerosis 90
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients 87
Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study. 80
Human polyomavirus JC replication and non coding control region analysis in multiple sclerosis patients under natalizumab treatment 79
Peripheral blood biomarkers in multiple sclerosis. 79
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 79
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 77
From high- to low-frequency administered interferon-beta for multiple sclerosis: A multicenter study 76
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 76
Ultrasonographic evaluation of cerebral arterial and venous haemodynamics in multiple sclerosis: a case-control study. 73
MR venography in patients with multiple sclerosis and correlation with clinical and MRI parameters 71
Autoantibodies to the adenosine triphosphate synthase play a pathogenetic role in Alzheimer's disease 70
Natalizumab affects T-cell phenotype in multiple sclerosis: implications for JCV reactivation 68
Dimethyl fumarate in the management of multiple sclerosis: Appropriate patient selection and special considerations 66
H-magnetic resonance spectroscopy. diagnostic tool in recurrent headache in systemic lupus erythematosus. a case report 65
Fingolimod vs dimethyl fumarate in multiple sclerosis. a real-world propensity score-matched study 63
Impaired cortical deactivation during hand movement in the relapsing phase of multiple sclerosis: a cross-sectional and longitudinal fMRI study 60
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 57
null 57
null 56
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus 56
Modificazioni immunofenotipiche dei linfociti T in pazienti affetti da sclerosi multipla in trattamento con natalizumab: implicazioni per la riattivazione del JC virus 51
CD49d expression on T lymphocytes and CD8 effector percentage as predictors of JC virus reactivation in multiple sclerosis patients on natalizumab treatment. 50
null 49
Human Polyomavirus JC monitoring and CD49d expression in dynamic cohorts of multiple sclerosis patients treated with natalizumab: an observational study. 42
Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by multiple sclerosis under treatment with natalizumab: an observational study 36
Chronic Cerebro-Spinal Venous Insufficiency is not significantly associated to Relapsing-Remitting Multiple Sclerosis. 34
Human Polyomavirus JC monitoring in dynamic cohorts of multiple sclerosis patients treated with natalizumab: an observational study 34
Neurological Involvement in Primary Sjogren Syndrome: A Focus on Central Nervous System 30
Olanzapine-induced neutropenia in a patient with systemic lupus erythematosus: a role of Fc gamma RIIIb polymorphism? 21
Cognitive fatigue in multiple sclerosis: an fMRI study 17
Somatosensory temporal discrimination threshold is impaired in patients with multiple sclerosis 14
Intradetrusorial botulinum toxin in patients with multiple sclerosis: A neurophysiological study 10
Totale 1.976
Categoria #
all - tutte 4.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.904


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020531 61 25 3 25 53 85 90 56 52 47 21 13
2020/2021130 17 15 8 3 2 10 8 5 23 23 15 1
2021/2022371 2 19 36 21 45 19 2 33 22 23 91 58
2022/2023382 74 86 34 30 40 33 12 14 26 6 15 12
2023/2024163 10 15 1 19 11 21 5 23 0 29 14 15
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 1.976